Itraconazole associated quadriparesis and edema: a case report

• Published in: Journal of medical case reports Vol. 5; no. 1; p. 140
• Main Authors: Karadi, Rangaprasad L, Gow, David, Kellett, Mark, Denning, David W, O'Driscoll, Ronan B
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 09.04.2011; BioMed Central; BMC
• Subjects: Care and treatment; Case Report; Case studies; Complications and side effects; Diagnosis; Dropsy; Edema; Itraconazole; Peripheral nerve diseases; Risk factors; United Kingdom
• ISSN: 1752-1947; 1752-1947
• DOI: 10.1186/1752-1947-5-140

Itraconazole is an anti-fungal agent widely used to treat various forms of mycosis. It is particularly useful in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. Side effects are uncommon and usually mild. Mild neuropathy is noted to occur very rarely. We present an unusual and, to the best of our knowledge, as yet unreported case of severe neuropathy and peripheral edema due to itraconazole in the absence of a concomitant risk factor. A 72-year-old Caucasian man was started on itraconazole following diagnosis of severe asthma with fungal sensitization. One month later he presented with severe bilateral ankle edema with an elevated serum itraconazole level. The itraconazole dose was reduced but his ankle edema persisted and he developed weakness of all four limbs. Itraconazole was completely stopped leading to improvement in his leg edema but he became bed bound due to weakness. He gradually improved with supportive care and neurorehabilitation. On review at six months, our patient was able to mobilize with the aid of two elbow crutches and power had returned to 5/5 in distal extremities and 4+/5 in proximal extremities. The diagnosis was established based on the classical presentation of drug-induced neuropathy and negative investigatory findings for any alternative diagnoses. We report the case of a patient presenting with an unusual complication of severe neuropathy and peripheral edema due to itraconazole. Clinicians should be alert to this association when encountered with neuropathy and/or edema in an itraconazole therapy recipient.